Central and Eastern Europe-the countries of the former Communist Bloc and Soviet Republics-are attractive destinations for clinical trials in terms of cost and low cultural barriers to doing business. In comparison with other emerging markets, such as India or China, the Central and Eastern European countries deliver higher quality data and have more efficient regulatory processes.